MedTrace Logo

Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients

NCT03759067 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 511

Last updated 2018-11-29

No results posted yet for this study

Summary

The study included 511 patients who underwent PCI because of angina during 2010-2011 at three Korean hospitals. Clopidogrel-naïve patients received either a loading dose (LD; 600 mg at 2-24 h before the procedure) or routine maintenance therapy (75 mg/day for ≥5 days) plus either a 300-mg reload (RL) or only the maintenance dose (MD).

Conditions

  • Angina, Stable

Interventions

DRUG

clopidogrel 75mg

clopidogrel once daily 75mg

DRUG

Clopidogrel 300 mg

clopidogrel 300mg reloading

DRUG

clopidogrel 600mg

clopidogrel 600mg loading

Sponsors & Collaborators

  • Korea University Anam Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-18
Primary Completion
2012-01-31
Completion
2013-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03759067 on ClinicalTrials.gov